Which funds bought or sold ROIV in Q3 2026?
Roivant Sciences Ltd. 6 funds bought, 4 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$545M.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- BlackRock+$499M
- Jennison+$277M
- Farallon+$272M
- State Street+$168M
- Legal & General+$34M
- Viking+$18M
- Goldman Sachs−$526M
- QRTOUT−$122M
- DME / Greenlight−$37M
- Maverick−$19M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (6)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| BlackRock Index giant | Added+28.3% | +$499M | $2.3B |
| Jennison Growth / crossover | Added+169.2% | +$277M | $441M |
| Farallon Hedge fund | Added+52% | +$272M | $795M |
| State Street Index giant | Added+25.9% | +$168M | $819M |
| Legal & General Asset manager | Added+128.6% | +$34M | $60M |
| Viking Hedge fund | Added+7.7% | +$18M | $247M |
Sold (4)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Goldman Sachs Bank & broker | Trimmed-77.4% | −$526M | $153M |
| QRT Quant & multi-strategy | Sold out | −$122M | — |
| DME / Greenlight Value investor | Trimmed-47.4% | −$37M | $41M |
| Maverick Hedge fund | Trimmed-18.4% | −$19M | $84M |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.